Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT

NCT00068770 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
35
Enrollment
OTHER
Sponsor class

Stopped EORTC trail showed TMZ \& RT conferred significant survivial in this population

Conditions

Interventions

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators